Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in adolescents with autism spectrum disorder
NCT02007447Phase 3Terminated
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jun 2015
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jun 2015; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02007447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007447.